HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Near-infrared chemical imaging (NIR-CI) of 3D printed pharmaceuticals.

Abstract
Hot-melt extrusion and 3D printing are enabling manufacturing approaches for patient-centred medicinal products. Hot-melt extrusion is a flexible and continuously operating technique which is a crucial part of a typical processing cycle of printed medicines. In this work we use hot-melt extrusion for manufacturing of medicinal films containing indomethacin (IND) and polycaprolactone (PCL), extruded strands with nitrofurantoin monohydrate (NFMH) and poly (ethylene oxide) (PEO), and feedstocks for 3D printed dosage forms with nitrofurantoin anhydrate (NFAH), hydroxyapatite (HA) and poly (lactic acid) (PLA). These feedstocks were printed into a prototype solid dosage form using a desktop 3D printer. These model formulations were characterized using near-infrared chemical imaging (NIR-CI) and, more specifically, the image analytical data were analysed using multivariate curve resolution-alternating least squares (MCR-ALS). The MCR-ALS algorithm predicted the spatial distribution of IND and PCL in the films with reasonable accuracy. In the extruded strands both the chemical mapping of the components in the formulation as well as the solid form of the active compound could be visualized. Based on the image information the total nitrofurantoin and PEO contents could be estimated., The dehydration of NFMH to NFAH, a process-induced solid form change, could be visualized as well. It was observed that the level of dehydration increased with increasing processing time (recirculation during the mixing phase of molten PEO and nitrofurantoin). Similar results were achieved in the 3D printed solid dosage forms produced from the extruded feedstocks. The results presented in this work clearly demonstrate that NIR-CI in combination with MCR-ALS can be used for chemical mapping of both active compound and excipients, as well as for visualization of solid form variation in the final product. The suggested NIR-CI approach is a promising process control tool for characterization of innovative patient-centred medicinal products.
AuthorsMilad Khorasani, Magnus Edinger, Dhara Raijada, Johan Bøtker, Johanna Aho, Jukka Rantanen
JournalInternational journal of pharmaceutics (Int J Pharm) Vol. 515 Issue 1-2 Pg. 324-330 (Dec 30 2016) ISSN: 1873-3476 [Electronic] Netherlands
PMID27720877 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Dosage Forms
  • Excipients
  • Pharmaceutical Preparations
  • Polyesters
  • polycaprolactone
  • Polyethylene Glycols
  • poly(lactide)
  • Durapatite
  • Nitrofurantoin
  • Indomethacin
Topics
  • Chemistry, Pharmaceutical (methods)
  • Dosage Forms
  • Durapatite (chemistry)
  • Excipients (chemistry)
  • Indomethacin (chemistry)
  • Least-Squares Analysis
  • Nitrofurantoin (chemistry)
  • Pharmaceutical Preparations (chemistry)
  • Polyesters (chemistry)
  • Polyethylene Glycols (chemistry)
  • Printing, Three-Dimensional
  • Spectroscopy, Near-Infrared (methods)
  • Technology, Pharmaceutical (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: